CRISPR Therapeutics AG (CRSP) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$50.01
-0.44%
Mkt Cap $4.84B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $4.72M | $864.00K | -81.69% | -$1.15 | -$1.37 | -19.13% |
| Q4 2025 Nov 10, 2025 | $9.12M | $889.00K | -90.25% | -$1.26 | -$1.17 | +7.14% |
| Q3 2025 Aug 4, 2025 | $9.44M | $892.00K | -90.55% | -$1.47 | -$1.29 | +12.24% |
| Q2 2025 May 6, 2025 | $5.96M | $865.00K | -85.50% | -$1.27 | -$1.58 | -24.41% |
| Q1 2025 Feb 11, 2025 | $8.06M | $35.00M | +334.51% | -$1.15 | -$0.44 | +61.74% |
| Q4 2024 Nov 5, 2024 | $7.70M | $602.00K | -92.18% | -$1.33 | -$1.01 | +24.06% |
| Q3 2024 Aug 5, 2024 | $16.57M | $517.00K | -96.88% | -$1.37 | -$1.49 | -8.76% |
| Q2 2024 May 8, 2024 | $3.54M | $504.00K | -85.76% | -$1.63 | -$1.43 | +12.27% |
| Q1 2024 Feb 21, 2024 | $28.11M | $200.00M | +611.49% | -$0.07 | $1.10 | +1671.43% |
| Q4 2023 Nov 6, 2023 | $7.96M | — | — | -$1.98 | -$1.41 | +28.79% |
| Q3 2023 Aug 7, 2023 | $1.71M | $70.00M | +3993.57% | -$2.18 | -$0.98 | +55.05% |
| Q2 2023 May 8, 2023 | $1.71M | $100.00M | +5747.95% | -$1.67 | -$0.67 | +59.88% |
| Q1 2023 Feb 21, 2023 | $22.98K | $6.00K | -73.89% | -$2.32 | -$1.41 | +39.22% |
| Q4 2022 Nov 1, 2022 | $1.85M | $94.00K | -94.91% | -$2.30 | -$2.24 | +2.61% |
| Q3 2022 Aug 8, 2022 | $2.21M | $158.00K | -92.86% | -$2.23 | -$2.40 | -7.62% |
| Q2 2022 May 9, 2022 | $2.80M | $178.00K | -93.64% | -$1.91 | -$2.32 | -21.47% |
| Q1 2022 Feb 15, 2022 | $2.19M | $12.35M | +465.05% | -$1.74 | -$1.84 | -5.75% |
| Q4 2021 Nov 3, 2021 | $833.75K | $329.00K | -60.54% | -$1.69 | -$1.67 | +1.18% |
| Q3 2021 Jul 29, 2021 | $845.94M | $900.20M | +6.41% | $3.52 | $9.44 | +168.18% |
| Q2 2021 Apr 27, 2021 | $1.21M | $202.00K | -83.31% | -$1.45 | -$1.51 | -4.14% |
| Q1 2021 Feb 16, 2021 | $2.50M | $194.00K | -92.24% | -$1.23 | -$1.50 | -21.95% |
| Q4 2020 Oct 28, 2020 | $132.30K | $148.00K | +11.86% | -$1.17 | -$1.32 | -12.82% |
| Q3 2020 Jul 27, 2020 | $32.15K | $44.00K | +36.85% | -$0.92 | -$1.30 | -41.30% |
| Q2 2020 Apr 28, 2020 | $143.35K | $157.00K | +9.52% | -$1.09 | -$1.15 | -5.50% |
| Q1 2020 Feb 12, 2020 | $95.14M | $77.02M | -19.05% | -$0.63 | $0.51 | +180.95% |
| Q4 2019 Oct 28, 2019 | $83.89M | $211.93M | +152.63% | -$0.95 | $2.40 | +352.63% |
| Q3 2019 Jul 29, 2019 | $283.37K | $318.00K | +12.22% | -$0.81 | -$1.01 | -24.69% |
| Q2 2019 Apr 29, 2019 | $310.37K | $328.00K | +5.68% | -$0.88 | -$0.93 | -5.68% |
| Q1 2019 Feb 25, 2019 | $97.50K | $115.00K | +17.95% | -$0.83 | -$0.92 | -10.84% |
| Q4 2018 Nov 7, 2018 | $389.36K | $563.00K | +44.59% | -$0.74 | -$1.07 | -44.59% |
| Q3 2018 Aug 7, 2018 | $835.90K | $1.09M | +30.16% | -$0.65 | -$0.82 | -26.15% |
| Q2 2018 May 8, 2018 | $1.47M | $1.36M | -7.46% | -$0.67 | -$0.62 | +7.46% |
| Q1 2018 Mar 8, 2018 | — | $32.33M | — | -$0.67 | $0.00 | +100.46% |
| Q4 2017 Nov 8, 2017 | $2.31M | $2.39M | +3.33% | -$0.60 | -$0.62 | -3.33% |
| Q3 2017 Aug 10, 2017 | $3.97M | $3.58M | -9.68% | -$0.62 | -$0.56 | +9.68% |
| Q2 2017 May 11, 2017 | $3.05M | $2.70M | -11.48% | -$0.51 | -$0.54 | -5.88% |
| Q1 2017 Mar 10, 2017 | $808.85K | $2.34M | +189.80% | -$0.38 | -$0.40 | -5.26% |
| Q4 2016 Nov 22, 2016 | $2.58M | $1.55M | -39.85% | -$0.72 | -$2.77 | -284.72% |
| Q4 2016 Oct 19, 2016 | — | $795.00K | — | — | -$0.43 | — |
| Q1 2016 Mar 31, 2016 | — | $476.00K | — | — | -$0.29 | — |
| Q4 2015 Dec 31, 2015 | — | $247.00K | — | — | -$0.42 | — |
| Q3 2015 Sep 30, 2015 | — | — | — | — | -$0.22 | — |
| Q2 2015 Jun 30, 2015 | — | — | — | — | -$0.66 | — |
| Q1 2015 Mar 31, 2015 | — | — | — | — | -$0.91 | — |